APP Roundtable: Addressing Co-Morbidities in CHB
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
APP Roundtable: Addressing Co-Morbidities in CHB
-
Lu par :
-
De :
À propos de ce contenu audio
In this expert-led podcast discussion, Patrick Horne and HoChong Gilles explore the complex management of comorbidities in patients with chronic viral hepatitis, with a focus on hepatitis B, hepatitis C, and HIV co-infection. The conversation highlights practical strategies for treatment sequencing, preventing hepatitis B reactivation during DAA therapy, managing drug–drug interactions, and optimizing long-term liver and systemic outcomes. The episode also examines the growing impact of metabolic dysfunction–associated steatotic liver disease (MASLD/MASH) on fibrosis progression and hepatocellular carcinoma (HCC) risk, along with current surveillance approaches including ultrasound and AFP. Additional insights address renal and bone health considerations with long-term hepatitis B antiviral therapy and the importance of multidisciplinary, whole-patient care when managing cardiovascular, metabolic, and renal co-morbidities in this high-risk population. Visit the GHAPP Digital Hub, Hep B Health Hub or GHAPP ACE app for more educational content.
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !